EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark QIXBELZA was filed as Word mark on 10/02/2017 at the European Union Intellectual Property Office.
It was registered as a trademark on 04/12/2018.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 017285784 |
| Application date | October 2, 2017 |
| Publication date | January 4, 2018 |
| Entry date | April 12, 2018 |
| Expiration date | October 2, 2027 |
Trademark owner
Lilly Corporate Center
46285 Indianapolis,
US
46285 Indianapolis,
US
Trademark representatives
Widenmayerstr. 10
80538 München
DE
goods and services
5
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, diagnosis and/or prevention of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders; pharmaceutical preparations, for the treatment, diagnosis and/or prevention of gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders; pharmaceutical preparations for the treatment, prevention and/or diagnosis of migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, pharmaceutical preparations, for the treatment, diagnosis and/or prevention of neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus and ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases; pharmaceutical preparations
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 5, 2019 | Change Representative, Published | ||
| December 20, 2018 | Change Representative, Published |
ID: 11017285784